[HTML][HTML] Perspective: repurposed drugs for COVID-19
K Na-Bangchang, S Porasuphatana… - Archives of Medical …, 2022 - ncbi.nlm.nih.gov
Methods Research articles and guidelines related to therapy of COVID-19 were searched
from the PubMed database. Results Only remdesivir and tocilizumab are medicines that …
from the PubMed database. Results Only remdesivir and tocilizumab are medicines that …
Old and re-purposed drugs for the treatment of COVID-19
SS Jean, PR Hsueh - Expert review of anti-infective therapy, 2020 - Taylor & Francis
Introduction: The coronavirus disease 2019 (COVID-19) caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …
Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action
The outbreak of a novel coronavirus (SARS-CoV-2) has caused a major public health
concern across the globe. SARS-CoV-2 is the seventh coronavirus that is known to cause …
concern across the globe. SARS-CoV-2 is the seventh coronavirus that is known to cause …
Current drugs with potential for coronavirus disease 2019 therapy: a literature review
S Alihosseini, HE Leylabadlo, M Parsaei… - … and Research in …, 2022 - journals.lww.com
Abstract Coronavirus disease 2019 (COVID-19) was declared as a pandemic by the WHO
on 2020 a novel disease with no confirmed and precise therapeutic agent …
on 2020 a novel disease with no confirmed and precise therapeutic agent …
COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
Y Song, M Zhang, L Yin, K Wang, Y Zhou… - International journal of …, 2020 - Elsevier
Currently, there is no approved therapy for coronavirus disease 2019 (COVID-19). The
World Health Organization (WHO) therefore endorses supportive care only. However …
World Health Organization (WHO) therefore endorses supportive care only. However …
[PDF][PDF] CURRENT THERAPEUTIC OPTIONS FOR CORONAVIRUS DISEASE-2019–A PHARMACOLOGICAL REVIEW
S MB, M JOSE, P KUTTICHIRA - Asian J Pharm Clin Res, 2020 - academia.edu
Objectives: Coronavirus pandemic is currently a global public health emergency. With
expanding knowledge of the virus and the disease, new therapeutic targets are emerging …
expanding knowledge of the virus and the disease, new therapeutic targets are emerging …
[HTML][HTML] Medical management of COVID-19: evidence and experience
Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …
Antiviral therapy of COVID-19
SM Janković - Scripta Medica, 2020 - aseestant.ceon.rs
The COVID-19 pandemic required rapid response to the needs of critically ill patients, and
one of the solutions was re-purposing of drugs with wide spectrum of antiviral action for …
one of the solutions was re-purposing of drugs with wide spectrum of antiviral action for …
Efficacy of the current investigational drugs for the treatment of COVID-19: a scoping review
To date, there is no final FDA-approved treatment for COVID-19. There are thousands of
studies published on the available treatments for COVID-19 virus in the past year. Therefore …
studies published on the available treatments for COVID-19 virus in the past year. Therefore …
An updated review on COVID-19
Coronavirus Disease (COVID-19) pandemic has affected more than seven million
individuals in 213 countries worldwide with a basic reproduction number ranging from 1.5 to …
individuals in 213 countries worldwide with a basic reproduction number ranging from 1.5 to …